March 29, 2024
“Shares of Viking Therapeutics (NASDAQ: VKTX) are up about 275% in 2023, but analysts on Wall Street think it isn’t finished climbing yet. The consensus price target on the clinical-stage biotech stock suggests a 47% gain could be up ahead…. Shares of Iovance Biotherapeutics (NASDAQ: IOVA) have more… Continue Reading…

Business
“Wendy’s, burned by CEO comment, vows no price surges for burgers”
March 4, 2024
“Wendy’s said on Wednesday it has no plans to raise menu prices at times of peak demand, after the burger chain was scorched on social media sites for comments its CEO made earlier this month suggesting the chain may start… Continue Reading…
Share this: